参考文献

[1]ALBAIN K S,SWANN R S,RUSCH V W,et al.Radiotherapy plus chemotherapy with or without surgical resection for stageⅢnon-small-cell lung cancer:a phaseⅢrandomised controlled trial[J].Lancet,2009,374(9687):379-386.

[2]FORDE P M,SPICER J,LU S,et al.Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer[J].N Engl J Med,2022,386(21):1973-1985.

[3]陆舜，王俊，王长利，等.中国肿瘤整合诊治指南（CACA）：结肠癌（2022）[M].天津：天津科学技术出版社，2022.

[4]陈孝平，汪建平，赵继宗.外科学[M].9版.北京：人民卫生出版社，2018.

[5]中国临床肿瘤学会指南工作委员会.小细胞肺癌诊疗指南（2020）[M].北京：人民卫生出版社，2020.

[6]SARUWATARI K,UMEMURA S,NOMURA S,et al.Prognostic factor analysis in patients with smallcell lung cancer treated with third-line chemotherapy[J].Clin Lung Cancer,2016,17(6):581-587.

[7]赫捷，魏文强.2019中国肿瘤登记年报[M].北京：人民卫生出版社，2021.

[8]GAY C M,STEWART C A,PARK E M,et al.Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities[J].Cancer Cell,2021,39(3):346-360.e7.